Archive | Actos Bladder Cancer RSS feed for this archive

Whistleblower Sues Takeda Pharmaceutical And Claims They Intentionally Underreported Actos Problems

Did Takeda Pharmaceutical not take reports of heart failure seriously in Actos patients? That’s the claim from a whistleblower who’s suing the company.  According to the suit, Takeda’s U.S. unit didn’t red-flag heart failure cases that weren’t fatal and didn’t require hospitalization when reporting them to the FDA, in order to one up the competition [...]

Read More

More Actos Bladder Cancer Lawsuits Popping Up Around The Country

On June 15, 2011, the U.S. Food & Drug Administration (FDA) issued a safety communication stating that use of Actos for more than one year may be associated with an increased risk of bladder cancer. The June safety communication was a follow-up to one the agency issued in September 2010 after preliminary data from a [...]

Read More

Actos Bladder Cancer Link

There is a consensus in the medical field that the exact causes of bladder cancer are unknown. However, in June 2011, the Food and Drug Administration (FDA) issued a warning to patients with type 2 diabetes. A review of a recent study revealed a possible link between taking Actos, a drug prescribed to type 2 [...]

Read More

Actos Side Effects Now Includes Bladder Cancer

Cancer of the bladder can be caused by cigarette smoking, radiation treatment, exposure to chemicals at work, and as a side effect of chemotherapy. Sometimes, and especially in women, bladder cancer originates from frequently recurring bladder and urinary tract infections. An additional cause of bladder cancer is the drug Actos (or pioglitazone). Actos is a [...]

Read More
Follow

Get every new post delivered to your Inbox.